A detailed history of Sargent Bickham Lagudis LLC transactions in Cvs Health Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 9,449 shares of CVS stock, worth $547,853. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,449
Previous 9,420 0.31%
Holding current value
$547,853
Previous $899,000 2.11%
% of portfolio
0.07%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$88.25 - $103.78 $2,559 - $3,009
29 Added 0.31%
9,449 $0
Q3 2022

Oct 27, 2022

SELL
$92.53 - $106.43 $10,640 - $12,239
-115 Reduced 1.21%
9,420 $899,000
Q2 2022

Jul 13, 2022

BUY
$88.66 - $106.64 $35,286 - $42,442
398 Added 4.36%
9,535 $883,000
Q1 2022

Apr 27, 2022

SELL
$100.77 - $110.83 $7,860 - $8,644
-78 Reduced 0.85%
9,137 $925,000
Q4 2021

Jan 18, 2022

BUY
$83.15 - $103.7 $9,978 - $12,444
120 Added 1.32%
9,215 $951,000
Q3 2021

Nov 05, 2021

BUY
$80.05 - $87.47 $76,607 - $83,708
957 Added 11.76%
9,095 $772,000
Q2 2021

Jul 19, 2021

BUY
$73.79 - $89.81 $21,546 - $26,224
292 Added 3.72%
8,138 $679,000
Q1 2021

May 24, 2021

BUY
$68.13 - $76.3 $27,728 - $31,054
407 Added 5.47%
7,846 $590,000
Q4 2020

May 24, 2021

SELL
$55.93 - $74.5 $22,763 - $30,321
-407 Reduced 5.19%
7,439 $508,000
Q4 2020

May 24, 2021

BUY
$55.93 - $74.5 $203,361 - $270,882
3,636 Added 86.37%
7,846 $590,000
Q3 2020

Sep 01, 2021

BUY
$56.71 - $65.71 $26,596 - $30,817
469 Added 12.54%
4,210 $246,000
Q2 2020

Sep 07, 2021

BUY
$55.41 - $70.62 $60,729 - $77,399
1,096 Added 41.44%
3,741 $243,000
Q1 2020

Sep 07, 2021

BUY
$52.3 - $76.05 $5,962 - $8,669
114 Added 4.5%
2,645 $157,000
Q4 2019

Sep 14, 2021

BUY
$60.38 - $76.58 $10,928 - $13,860
181 Added 7.7%
2,531 $188,000
Q3 2019

Sep 14, 2021

BUY
$54.09 - $64.3 $4,922 - $5,851
91 Added 4.03%
2,350 $148,000
Q2 2019

Sep 13, 2021

BUY
$52.13 - $57.33 $15,378 - $16,912
295 Added 15.02%
2,259 $123,000
Q1 2019

Sep 13, 2021

BUY
$52.36 - $69.88 $14,032 - $18,727
268 Added 15.8%
1,964 $106,000
Q4 2018

Sep 13, 2021

BUY
$62.92 - $80.8 $2,705 - $3,474
43 Added 2.6%
1,696 $111,000
Q3 2018

Sep 13, 2021

BUY
$63.78 - $79.59 $22,578 - $28,174
354 Added 27.25%
1,653 $130,000
Q2 2018

Sep 13, 2021

SELL
$60.71 - $72.18 $9,349 - $11,115
-154 Reduced 10.6%
1,299 $84,000
Q1 2018

Sep 13, 2021

BUY
$60.6 - $83.63 $8,544 - $11,791
141 Added 10.75%
1,453 $90,000
Q4 2017

Sep 13, 2021

BUY
$66.8 - $80.91 $72,277 - $87,544
1,082 Added 470.43%
1,312 $95,000
Q2 2017

Sep 13, 2021

BUY
N/A
29 Added 14.43%
230 $18,000
Q1 2017

Sep 13, 2021

SELL
N/A
-610 Reduced 75.22%
201 $16,000
Q4 2016

Sep 13, 2021

SELL
N/A
-135 Reduced 14.27%
811 $64,000
Q3 2016

Sep 13, 2021

SELL
N/A
-37,420 Reduced 97.53%
946 $3.31 Million
Q2 2016

Sep 07, 2021

SELL
N/A
-2,481 Reduced 6.07%
38,366 $3.67 Million
Q1 2016

Sep 07, 2021

BUY
N/A
40,847
40,847 $4.24 Million

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $76.1B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.